Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary pulmonary hypertension: recent advances.

S Rich

    Herz
    |August 1, 1986
    PubMed
    Summary

    Primary pulmonary hypertension (PPH) affects all ages, with new insights into its causes and features. Current treatments, especially vasodilators, show limited long-term benefits, necessitating earlier diagnosis and targeted therapies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Levosimendan in intensive care and emergency medicine: literature update and expert recommendations for optimal efficacy and safety.

    Journal of anesthesia, analgesia and critical care·2023
    Same author

    Comparison of molecular detection methods for pertussis in children during a state-wide outbreak.

    Annals of clinical microbiology and antimicrobials·2016
    Same author

    Plasma von Willebrand factor as a predictor of survival in pulmonary arterial hypertension associated with congenital heart disease.

    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2011
    Same author

    Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation.

    The European respiratory journal·2009
    Same author

    Association between birth weight and adolescent systolic blood pressure in a caucasian birth cohort differs according to skin type, CRH promoter or 11beta-HSD2 genotype.

    Archives of disease in childhood·2008
    Same author

    A USA-based registry for pulmonary arterial hypertension: 1982-2006.

    The European respiratory journal·2007

    Area of Science:

    • Cardiology
    • Pulmonology
    • Pathophysiology

    Background:

    • Primary pulmonary hypertension (PPH) was historically considered a disease of younger women but now affects all age groups.
    • The female to male ratio is approximately 1.7:1 across all ages.
    • Recent research has elucidated several potential pathogenic mechanisms.

    Purpose of the Study:

    • To review newer insights into the pathogenic mechanisms, clinical features, and treatment of PPH.
    • To critically evaluate the effectiveness of current therapeutic strategies, particularly vasodilators.
    • To emphasize the importance of early diagnosis for improving patient prognosis.

    Main Methods:

    • Literature review of recent studies on PPH.
    • Analysis of proposed etiologic mechanisms including thromboxane, clot lysis abnormalities, antinuclear antibodies, and hormonal influences.
    • Evaluation of clinical trial data on vasodilator efficacy and anticoagulation therapy.

    Main Results:

    • Potential roles for thromboxane, impaired clot lysis, antinuclear antibodies, and female hormones in PPH pathogenesis are suggested.
    • Chronic vasodilator use has not consistently altered the clinical course or survival in PPH patients.
    • Beneficial effects of vasodilators may occur with substantial pulmonary artery pressure reduction, but careful interpretation of their physiological impact is crucial.

    Conclusions:

    • Effective treatment for PPH remains a significant challenge.
    • The development of more specific vasodilators for the pulmonary vascular bed may improve outcomes.
    • Earlier diagnosis strategies are critical for improving the prognosis of primary pulmonary hypertension.

    Related Experiment Videos